Robbert Spaapen is an Associate Director at AstraZeneca, specializing in T cell biology and immune responses. With a PhD cum laude from Utrecht University, Robbert focused on identifying minor histocompatibility antigens during their doctoral research, which contributed to effective immunotherapy strategies for hematological cancers. Following postdoctoral work at the University of Chicago and NKI, Robbert led innovative research at Sanquin and served as an Associate Professor at Amsterdam UMC. Currently, as a principal scientist at Neogene Therapeutics, Robbert continues to advance tumor antigen identification while applying diverse expertise in immune regulation and high-throughput screening techniques.
This person is not in the org chart
This person is not in any teams
This person is not in any offices